The London Clinic will be the first facility to use Aclarion’s technology, which helps identify the location of chronic lower back pain, according to a May 30 news release.
Aclarion has added multiple advisers to its team, most recently Dean Karahalios, MD. The company is also working on a post-market trial for Nociscan.
